The Next Generation Biotech Media
By T. Chakraborty, Ph.D. Pharma giant Novartis is spending $69 million upfront to acquire two experimental drugs (MP0420 and MP0423) from Molecular Partners (MP) for combatting COVID-19. The drugs which …
Read More
By Tyler Chen As the only influenza vaccine manufacturer with both EU GMP and US FDA certification in Asia and the only PIC/S GMP manufacturer of human vaccines in Taiwan, …
Read More
By T. Chakraborty, Ph.D. & Rajaneesh K. Gopinath, Ph.D. On October 22nd, Atea Pharmaceuticals, Inc. announced that it had entered into an arrangement with Roche for the exclusive rights to …
Read More
By Daniel Ojeda, Ph.D. On October 22nd, Remdesivir (Veklury) was approved by the U.S. Food and Drug Administration (FDA) to treat patients with COVID-19. The approval comes days after the …
Read More
By T. Chakraborty, Ph.D. In the last couple of decades, genome editing techniques have revolutionized various aspects of biological research. With improvements in technology over time, the scientific community is …
Read More
By Tyler Chen On October 12th, Taiwan’s TTY Biopharm Company Limited received the authorization for delivering COVID-19 vaccines produced by BioNTech. Around 30 million vaccines will be delivered to Taiwan, …
Read More
By Rajaneesh K. Gopinath, Ph.D. China-based Sinovac Biotech may initiate a Phase 3 clinical trial of its inactivated COVID-19 vaccine, CoronaVac, in the Philippines as early as next month. Philippine …
Read More
By Sangeeta Chakraborty, Ph.D. Indianapolis-based Eli Lilly’s leading antibody treatment for coronavirus, currently in three major clinical trials, recently came under the scrutiny of government health officials who asked the …
Read More
By T. Chakraborty, Ph.D. As the clock keeps ticking, scientists worldwide are trying their best to develop an effective cure for COVID-19. Among the frontrunners, Moderna and AstraZeneca’s vaccine candidates …
Read More
By Sahana Shankar, Ph.D. Candidate A COVID-19 diagnosis can result in a wide spectrum of clinical conditions ranging from asymptomatic, mild flu-like symptoms, severe pulmonary distress to multiple organ failure. …
Read More